Rachel Salazar

Rachel Salazar is a passionate and adaptive organizational leader with drug development experience across multiple modalities from pre-IND through life cycle management. Skilled in strategy development, portfolio management, and prioritization.

In-depth oncology & immuno-oncology experience acquired from various leadership roles at EMD Serono, Inc., Takeda Oncology, and Pfizer. Rachel holds a D.H.Sc from Eastern Virginia Medical School; master’s degree in Biomedical Engineering from Tufts University